Immunological and Clinical Responses to Zinc in Children With Diarrhoea
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00408356|
Recruitment Status : Completed
First Posted : December 6, 2006
Last Update Posted : February 20, 2009
|Condition or disease||Intervention/treatment||Phase|
|Diarrhoea||Drug: Zinc||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||338 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Immunological and Clinical Responses to Zinc: A Randomized, Double-Blind Trial of Zinc Treatment vs. Zinc Treatment Plus Daily Supplementation for 3 Months Among Children Under 2 Years of Age With an Acute Diarrheal Illness.|
|Study Start Date :||November 2004|
|Actual Primary Completion Date :||August 2006|
|Actual Study Completion Date :||November 2006|
- To evaluate innate and adaptive immune response.
- Future occurrence of acute diarrhoea, ARI and impetigo.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00408356
|ICDDR,B. Mirpur Field Site|
|Dhaka, Bangladesh, 1212|
|Study Director:||Amit Saha, MBBS||International Centre for Diarrhoeal Disease Research, Bangladesh|